Theravance Biopharma, Inc. Financial Ratios — TBPH Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-1,241.48	-130.62	-57.13	-40.6	-52.82	-43.03	-48.8	-63.34	-47.26	177.58	-11.16	-15.33	25.22
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-12.46
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.02
Gross Margin (%)	100	100	65.28	88.95	94.05	60.81	98.82	100	100	100	100	100	100	100
EBITDA Margin (%)	-4.86	-67,978.32	-1,961.54	-424.7	-364.55	-1,664.47	-390.24	-334.68	-404.49	-414.1	-140.41	-85.39	-60.3	-0.74
Operating Margin (%)	-7.36	-69,152.21	-1,989.55	-431.8	-370.96	-1,690.65	-395.48	-343.14	-414.19	-429.65	-154.09	-92.8	-65.91	-3.35
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-7.36	-69,152.21	-1,973.6	-430.3	-371.15	-1,765.96	-374.5	-329.2	-422.15	-479.51	-180.76	-85.8	-69.3	120.27
Profit Margin (%)	-7.36	-69,152.21	-2,028.05	-432.56	-391.94	-1,854.97	-357.01	-322.08	-386.9	-360.55	1,698.54	-96.11	-87.63	98.54
Net Income to Common Margin (%)	-7.36	-69,152.21	-2,028.05	-432.56	-391.94	-1,854.97	-357.01	-322.08	-386.9	-360.55	1,698.54	-96.11	-87.63	98.54
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.07
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	223	224	454	511	676	670	52	49	50	43
ST Debt	- -	- -	- -	- -	- -	- -	- -	18	29	17	7	4	11	11
LT Debt	- -	- -	- -	- -	223	224	454	493	647	652	45	45	39	32
Total Debt/EBITDA	- -	- -	- -	- -	-1.26	-0.87	-1.93	-2.08	-2.33	-2.92	-0.72	-1	-1.28	-53.99
Net Debt/EBITDA	- -	- -	0.39	0.63	0.69	-0.53	-0.32	-1.62	-1.85	-2.3	4.14	0.81	0.97	212.14
Total Debt/EBIT	- -	- -	- -	- -	-1.23	-0.86	-1.9	-2.03	-2.27	-2.82	-0.66	-0.92	-1.17	-11.86
Net Debt/EBIT	- -	- -	0.38	0.62	0.68	-0.52	-0.32	-1.58	-1.81	-2.21	3.77	0.74	0.89	46.59
EBITDA to Interest Expense	- -	- -	- -	- -	-126.32	-29.96	-22.48	-7.71	-34.01	-26.8	-11.32	-20.87	-15.25	-0.32
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-127.84	-30.24	-23.17	-7.81	-34.78	-27.2	-11.41	-21.93	-15.38	-0.34
EBIT to Interest Expense	- -	- -	- -	- -	-128.54	-30.43	-22.78	-7.91	-34.82	-27.8	-12.42	-22.68	-16.67	-1.46
Interest Expense	- -	- -	- -	- -	1	9	10	32	9	9	6	2	3	2
Common Equity/Total Assets	- -	-67.66	-41.25	-107.14	-80.13	-180.73	-180.66	-305.41	-325.46	-460.5	-140.58	-237.99	-272.62	-177.03
Long-Term Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	- -	- -	- -	- -	10.28	21.24	22.28	10.7
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-76.9	-38.98	-81.46	-66.78	-76.09	-61.72	-5.66	-5.26	-4.27	-3.89
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	120.57	137.95	173.97	7.48	11.84	11.04	6.54
Total Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	-880.72	-228.08	-222.64	-197.75	11.81	23.08	28.38	14.39
Total Debt/Capital (%)	- -	- -	- -	- -	-76.9	-38.98	-81.46	-69.17	-79.53	-63.37	-6.51	-5.72	-5.44	-5.23
Total Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	124.88	144.17	178.62	8.59	12.87	14.07	8.79
Net Debt to Equity	- -	- -	-30.79	-46.37	-34.84	117.01	-147.96	-177.35	-177.02	-155.47	-67.49	-18.57	-21.53	-56.55
Net Debt/Capital (%)	- -	- -	39.03	25.95	19.24	-20.33	-8.16	-49.86	-57.7	-45.91	27.11	4.4	3.96	17.04
EBITDA	-6	-154	-229	-179	-177	-256	-236	-246	-291	-229	-72	-49	-39	-1
EBITDA-CapEx	-9	-156	-232	-182	-179	-259	-243	-249	-297	-232	-73	-52	-39	-1
Operating Income (Loss)	-10	-156	-233	-182	-180	-260	-239	-252	-298	-238	-79	-53	-42	-4

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	- -	6.17	3.49	10.17	5.57	5.13	2.51	2.37	2.96	11.4	4.14	2.75	8.23
Current Ratio	- -	0.38	6.67	4.8	10.73	6.05	5.41	3.03	3.18	4.26	12.31	5.39	5.02	10.93
Quick Ratio	- -	0.03	6.22	4.24	10.37	5.72	5.29	2.97	2.93	3.94	11.99	4.84	4.89	10.73
CFO/Avg Current Liab	- -	-6.56	-4.48	-3.72	-2.01	-3.6	-1.4	-2.27	-2.13	-2.28	-4.28	-1.01	-0.41	6.78
Common Equity/Total Assets	- -	-67.66	-41.25	-107.14	-80.13	-180.73	-180.66	-305.41	-325.46	-460.5	-140.58	-237.99	-272.62	-177.03
Long-Term Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	- -	- -	- -	- -	10.28	21.24	22.28	10.7
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-76.9	-38.98	-81.46	-66.78	-76.09	-61.72	-5.66	-5.26	-4.27	-3.89
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	120.57	137.95	173.97	7.48	11.84	11.04	6.54
Total Debt/Equity (%)	- -	- -	- -	- -	63.58	194.26	-880.72	-228.08	-222.64	-197.75	11.81	23.08	28.38	14.39
Total Debt/Capital (%)	- -	- -	- -	- -	-76.9	-38.98	-81.46	-69.17	-79.53	-63.37	-6.51	-5.72	-5.44	-5.23
Total Debt/Total Assets (%)	- -	- -	- -	- -	34.83	50.69	81.1	124.88	144.17	178.62	8.59	12.87	14.07	8.79
CFO/Total Liabilities	- -	-286.55	-365.03	-295.98	-34.25	-61.63	-18.45	-37.65	-32.4	-29.14	-112.92	-15.97	-6.46	126.31
CFO/CapEx	-45.99	-44.24	-56.37	-63.79	-46.36	-83.56	-15.59	-75	-37.85	-61.03	-326.91	-10.85	-34.74	5,679.55
Altman's Z-Score	- -	-22.51	3.94	3.28	1.88	-0.9	-1.54	-4.1	-4.95	-7.13	1.32	-1.09	-2.05	1.65

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.4	7.17	2.14	2.08	1.61	6.03	4.49	3.8	3.7	3.33	3.35	3.59	3.36
Days Sales Outstanding	- -	914.92	50.93	170.18	175.85	226.36	60.57	81.21	96.17	98.76	109.65	108.88	101.8	108.65
Inventory Turnover	- -	- -	0.35	0.41	0.26	0.42	0.08	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	1,032.22	883.74	1,401.54	879.21	4,295.77	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	3	0.74	0.15	0.5	2.78	-2.16	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	121.71	496.47	2,477.46	733.61	131.33	-169.33	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	586.68	-1,423.54	843.79	974.24	4,525.66	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	-981.28	-713.55	-1,225.69	-652.84	-4,235.2	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	10	13	10	12	17	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	5	7	7	6	12	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	5	6	3	4	5	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	474	560	1,425	1,460	1,381	1,440	1,108	768	826	622	460	941
- Cash & Cash Equivalents	- -	- -	89	113	345	89	378	58	81	90	298	40	38	168
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	223	224	454	511	676	670	52	49	50	43
Enterprise Value	- -	- -	219	387	1,147	1,335	1,330	1,669	1,491	1,264	550	568	421	669
Total Capital	- -	-17	-139	-322	-290	-574	-558	-738	-850	-1,057	-802	-860	-916	-817
Total Debt/Capital (%)	- -	- -	- -	- -	-76.9	-38.98	-81.46	-69.17	-79.53	-63.37	-6.51	-5.72	-5.44	-5.23
Total Debt / EV	- -	- -	- -	- -	0.19	0.17	0.34	0.31	0.45	0.53	0.09	0.09	0.12	0.06
EV/Sales	- -	- -	18.75	9.19	23.58	86.79	22.03	22.74	20.75	22.85	10.72	9.9	6.54	6.22
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.78
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.78
Diluted Market Cap	- -	- -	474	560	1,425	1,460	1,381	1,440	1,108	768	826	622	460	964
Diluted Enterprise Value	- -	- -	385	447	1,303	1,595	1,457	1,892	1,703	1,347	580	631	472	839
EV per Share	- -	- -	6.9	11.34	25.65	25.51	24.65	30.02	23.92	18.19	7.48	10.28	8.62	13.29
TTM Sales	130	- -	12	42	49	15	60	73	72	55	51	57	64	107
TTM EBITDA	-6	-154	-229	-179	-177	-256	-236	-246	-291	-229	-72	-49	-39	-1
TTM Operating Income	-10	-156	-233	-182	-180	-260	-239	-252	-298	-238	-79	-53	-42	-4
TTM Cash Flow to Firm	-119	-121	-175	-169	-98	-192	-103	-207	-242	-199	-181	-24	-8	241
TTM Free Cash Flow to Firm	-117	-118	-172	-166	-95	-190	-96	-204	-235	-196	-180	-22	-8	241

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-2.75	-3.37	-14.72	-7.35	-13.07	-6.13	-4.54	-3.75	-4.43	-25.36	-41.03	4.04
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	219	387	1,147	1,335	1,330	1,669	1,491	1,264	550	568	421	669
Low Price	- -	- -	13.11	10.56	12.87	23.15	21.27	15.18	14.48	6.1	7.53	8.25	7.44	7.9
EV/Sales	- -	- -	18.75	9.19	23.58	86.79	22.03	22.74	20.75	22.85	10.72	9.9	6.54	6.22
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.95	- -	- -	8.89
Price/Earnings Average	- -	- -	-3.21	-2.92	-5.69	-6.09	-6.6	-5	-4.89	-5	0.82	-10.35	-7.8	5.76
Price/Earnings High	- -	- -	-4.78	-4.12	-9.13	-7.97	-8.88	-6.73	-7.07	-7.92	1.11	-12.05	-10.14	9.66
Price/Earnings Low	- -	- -	-1.76	-1.98	-3.02	-4.25	-5.33	-3.57	-3.25	-2.12	0.64	-8.27	-6.44	3.75
Price/Book Value	- -	- -	-3.4	-1.74	-2.78	-1.83	-1.36	-1.15	-0.73	-0.44	-0.97	-0.68	-0.48	-1.1
Price/Book Value Average	- -	- -	-5.46	-1.65	-2.12	-2.18	-1.4	-0.95	-0.89	-0.58	-0.84	-0.63	-0.46	-0.71
Price/Book Value High	- -	- -	-8.13	-2.34	-3.4	-2.85	-1.89	-1.28	-1.29	-0.92	-1.14	-0.73	-0.59	-1.19
Price/Book Value Low	- -	- -	-2.99	-1.12	-1.12	-1.52	-1.13	-0.68	-0.59	-0.25	-0.65	-0.5	-0.38	-0.46
Price/Tangible Book Value	- -	- -	1.63	2.3	4.07	12.68	-26.77	-6.43	-3.65	-2.27	1.87	2.92	2.62	3.17
Price/Tangible Book Value Average	- -	- -	2.63	2.19	3.1	15.08	-27.56	-5.28	-4.48	-2.94	1.62	2.68	2.51	2.06
Price/Tangible Book Value High	- -	- -	3.91	3.09	4.97	19.74	-37.12	-7.11	-6.47	-4.67	2.19	3.12	3.26	3.45
Price/Tangible Book Value Low	- -	- -	1.44	1.48	1.64	10.52	-22.25	-3.77	-2.97	-1.25	1.25	2.14	2.07	1.34
Price/Sales	- -	- -	40.54	13.29	29.3	94.9	22.88	19.61	15.42	13.88	16.08	10.82	7.14	8.76
Price/Sales Average	- -	- -	65.11	12.63	22.31	112.89	23.55	16.11	18.92	18.02	13.94	9.95	6.84	5.68
Price/Sales High	- -	- -	96.93	17.83	35.77	147.81	31.72	21.69	27.36	28.56	18.88	11.59	8.88	9.52
Price/Sales Low	- -	- -	35.62	8.56	11.83	78.78	19.01	11.5	12.56	7.66	10.79	7.95	5.64	3.7
Price/Cash Flow	- -	- -	-2.7	-3.31	-14.4	-7.26	-12.24	-6.04	-4.42	-3.69	-4.42	-23.02	-39.85	3.95
Price/Cash Flow Average	- -	- -	-4.34	-3.15	-10.96	-8.64	-12.6	-4.97	-5.43	-4.8	-3.83	-21.16	-38.15	2.56
Price/Cash Flow High	- -	- -	-6.47	-4.45	-17.58	-11.31	-16.97	-6.68	-7.85	-7.6	-5.18	-24.64	-49.59	4.29
Price/Cash Flow Low	- -	- -	-2.38	-2.14	-5.81	-6.03	-10.17	-3.54	-3.61	-2.04	-2.96	-16.9	-31.51	1.67
Price/Free Cash Flow Average	- -	- -	-4.42	-3.2	-11.2	-8.74	-13.46	-5.03	-5.58	-4.88	-3.84	-23.31	-39.29	2.62
Price/Free Cash Flow High	- -	- -	-6.58	-4.52	-17.97	-11.45	-18.13	-6.77	-8.07	-7.73	-5.2	-27.14	-51.06	4.39
Price/Free Cash Flow Low	- -	- -	-2.42	-2.17	-5.94	-6.1	-10.87	-3.59	-3.7	-2.07	-2.97	-18.62	-32.44	1.71
EV/Sales Average	- -	- -	57.48	9.95	19.8	121.64	24.82	22.27	27.2	28.5	9.14	10.12	7.02	4.51
EV/Sales High	- -	- -	89.29	15.16	33.26	156.57	32.98	27.85	35.64	39.04	14.08	11.75	9.07	8.35
EV/Sales Low	- -	- -	27.99	5.89	9.32	87.54	20.28	17.66	20.84	18.14	6	8.11	5.83	2.53
EV/EBITDA Average	- -	- -	-2.93	-2.34	-5.43	-7.31	-6.36	-6.66	-6.72	-6.88	-6.51	-11.85	-11.65	-613.19
EV/EBITDA High	- -	- -	-4.55	-3.57	-9.12	-9.41	-8.45	-8.32	-8.81	-9.43	-10.03	-13.76	-15.04	-1,135.07
EV/EBITDA Low	- -	- -	-1.43	-1.39	-2.56	-5.26	-5.2	-5.28	-5.15	-4.38	-4.27	-9.5	-9.67	-344.38
EV/EBIT Average	- -	- -	-2.89	-2.31	-5.34	-7.2	-6.28	-6.49	-6.57	-6.63	-5.93	-10.9	-10.65	-134.66
EV/EBIT High	- -	- -	-4.49	-3.51	-8.97	-9.26	-8.34	-8.12	-8.61	-9.09	-9.14	-12.66	-13.76	-249.26
EV/EBIT Low	- -	- -	-1.41	-1.36	-2.51	-5.18	-5.13	-5.15	-5.03	-4.22	-3.89	-8.74	-8.85	-75.63
Last Price	- -	- -	14.92	16.39	31.88	27.89	25.59	25.89	17.77	11.05	11.22	11.24	9.41	18.71
High Price	- -	- -	35.67	22	38.92	43.44	35.48	28.63	31.54	22.74	13.17	12.03	11.71	20.33
Enterprise Value Average	- -	- -	672	419	963	1,872	1,498	1,635	1,955	1,576	470	581	452	485
Enterprise Value High	- -	- -	1,044	639	1,618	2,409	1,991	2,045	2,561	2,159	723	675	584	898
Enterprise Value Low	- -	- -	327	248	453	1,347	1,224	1,297	1,498	1,003	308	466	375	272

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	32	32	38	53	54	56	57	64	74	65	48	49	51
Diluted Weighted Avg Shares	32	32	32	34	45	52	54	56	62	69	74	55	49	52
Basic Weighted Avg Shares	32	32	32	34	45	52	54	56	62	69	74	55	49	50
Revenue per Share	4.03	0.01	0.37	1.23	1.09	0.29	1.12	1.32	1.15	0.8	0.7	1.04	1.32	2.14
EBITDA per Share	-0.2	-4.76	-7.22	-5.24	-3.97	-4.89	-4.37	-4.42	-4.66	-3.3	-0.98	-0.89	-0.79	-0.02
Operating Income per Share	-0.3	-4.84	-7.32	-5.33	-4.04	-4.97	-4.42	-4.53	-4.77	-3.42	-1.08	-0.96	-0.87	-0.07
Basic EPS, GAAP	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.46	-2.87	11.85	-1	-1.15	2.1
Basic EPS from Cont Ops	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.73	-3.82	-1.26	-1	-1.15	2.1
Diluted EPS, GAAP	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.46	-2.87	11.85	-1	-1.15	2.06
Diluted EPS from Cont Ops	-0.3	-4.84	-7.46	-5.34	-4.26	-5.45	-3.99	-4.25	-4.73	-3.82	-1.26	-1	-1.15	2.06
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.69	-3.75	-5.52	-4.94	-2.21	-3.84	-2.09	-4.28	-4.02	-2.99	-2.54	-0.49	-0.24	4.74
Free Cash Flow per Basic Share	-3.77	-3.83	-5.61	-5.02	-2.26	-3.89	-2.23	-4.34	-4.12	-3.04	-2.55	-0.53	-0.24	4.74
Cash & Equivalents per Share	- -	- -	8.02	5.05	11.21	6.66	9.36	5.05	4.7	2.5	4.45	1.85	1.81	6.27
Book Value per Share	- -	-0.53	-4.39	-9.42	-11.46	-15.24	-18.75	-22.45	-24.49	-24.85	-11.6	-16.44	-19.77	-17.08
Tangible Book Value per Share	- -	-0.53	9.13	7.12	7.83	2.2	-0.96	-4.03	-4.87	-4.87	6	3.85	3.59	5.9

Theravance Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)